| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.84B | 49.93B | 46.81B | 43.92B | 43.41B | 41.40B |
| Gross Profit | 7.25B | 8.00B | 6.85B | 6.23B | 5.55B | 6.44B |
| EBITDA | 3.24B | 3.85B | 2.79B | 2.10B | 1.48B | 2.17B |
| Net Income | 1.47B | 1.87B | 1.18B | 881.00M | 1.65B | 725.00M |
Balance Sheet | ||||||
| Total Assets | 51.17B | 53.42B | 50.83B | 52.47B | 47.80B | 47.31B |
| Cash, Cash Equivalents and Short-Term Investments | 3.42B | 4.23B | 3.70B | 3.74B | 3.38B | 3.62B |
| Total Debt | 7.28B | 6.21B | 6.92B | 7.53B | 7.55B | 9.19B |
| Total Liabilities | 21.26B | 21.48B | 21.00B | 23.06B | 20.53B | 21.62B |
| Stockholders Equity | 29.70B | 31.72B | 29.63B | 29.21B | 27.09B | 25.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 431.00M | 337.00M | 753.00M | 1.55B | 300.00M |
| Operating Cash Flow | 0.00 | 2.38B | 2.28B | 2.01B | 2.77B | 1.85B |
| Investing Cash Flow | 0.00 | 98.00M | -1.18B | -1.31B | -1.21B | -1.47B |
| Financing Cash Flow | 0.00 | -1.97B | -1.25B | -398.00M | -2.01B | 39.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥111.87B | 8.38 | ― | 3.72% | 4.49% | 27.96% | |
73 Outperform | ¥75.50B | 9.11 | ― | 3.04% | -0.37% | -20.95% | |
69 Neutral | ¥16.37B | 9.23 | ― | 3.61% | 6.67% | 66.03% | |
69 Neutral | ¥555.50B | 21.11 | ― | 3.26% | 15.83% | 124.18% | |
64 Neutral | ¥421.88B | 4.51 | 8.14% | 2.61% | -0.45% | 50.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | ¥34.62B | 20.68 | ― | 3.70% | 29.30% | -82.16% |